uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Ginkgo biloba and its Influence on Nanoplaque Formation and Vascular Function
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
Show others and affiliations
2008 (English)In: Diabetes stoffwechsel und herz, ISSN 1861-7603, Vol. 17, S23-S35 p.Article in journal (Refereed) Published
Abstract [en]

Background: In a pilot study, we demonstrated the beneficial effects of Ginkgo biloba (EGb 761) on atherosclerotic nanoplaque formation and size, the oxLDL/LDL quotient and the lipoprotein(a) concentration, the increase in superoxide dismutase activity, as well as the cAMP and cGMP concentrations. Method: The measurable variables formerly used were supplemented by a biomarker spectrum, through which the latest parameter and markers of plaque stability and progression, oxidative stress, and inflammation could be determined. Results: In 11 patients with early-stage metabolic syndrome, atherosclerotic nanoplaque formation fell by 14.3 +/- 2.9 (p < 0.0077) and nanoplaque size by 23.4 +/- 3.7 % (p < 0.0004), respectively, after a two-month regime with Ginkgo biloba extract. Superoxide dismutase and glutathione peroxidase (GPx) activities were upregulated by 19.6 +/- 10.0 % (p < 0.0785) and 11.6 +/- 2.3 % (p < 0.001), respectively. The quotient oxLDL/LDL fell by 21.0 +/- 4.3 % (p < 0.002), and lipoprotein(a) concentration by 26.3 t 4.8 % (p < 0.001). The concentrations of cAMP and cGMP were augmented by43.5 12.0% (p < 0.001)and 32.9 +/- 10.4% (p < 0.001), respectively. The serum Call concentration fell by 5.4 +/- 1.6 % (p < 0.0076). We could also show a favourable development of 8-iso-PGF(2 alpha), oxLDL/LDL, SOD, GPx, hsCRP MPO,TNF alpha, TGF beta(1), and MMP-9. Conclusion: Ginkgo with its pleiotropic effects should be assigned a fixed rank among the anti-ageing medical therapeutics.

Place, publisher, year, edition, pages
2008. Vol. 17, S23-S35 p.
Keyword [en]
metabolic syndrome, Ginkgo biloba, nanoplaque formation, nanoplaque size
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-149183ISI: 000261775900005OAI: oai:DiVA.org:uu-149183DiVA: diva2:404098
Available from: 2011-03-15 Created: 2011-03-15 Last updated: 2011-03-15Bibliographically approved

Open Access in DiVA

No full text

By organisation
Department of Pharmacy
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 355 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf